Dr. Daniel Von Hoff, Physician-In-Chief of the Translational
Genomics Research Institute (TGen), has won an award recognizing
his achievements in cancer research.
Dr. Von Hoff, who also is Chief Scientific Officer of TGen
Clinical Research Services at Scottsdale Healthcare, will be
recognized in the category of Health Care Research in a special
report this month in Arizona Business Magazine. Dr. Von Hoff was
honored March 4 at the magazine's 2009 Health Care Leadership
Awards at the Ritz Carlton Phoenix.
This is the second major award in recent months for Dr. Von Hoff,
a world-renowned cancer scientist and one of the leading experts in
pancreatic cancer. In November, Dr. Von Hoff was named Arizona's
Community Service Leader of the Year at the 2008 Governor's
Celebration of Innovation, presented annually for contributions to
Arizona's technology industry through relentless community
involvement, leadership, visibility and excellence in economic
development activity.
For more than 30 years, Dr. Von Hoff has dedicated his time and
experience to the study of cancer and treatment methods. Arizona
Business Magazine cited his:
- International leadership in bringing to patients new anti-cancer agents - many of which have been shown to increase patient survival.
- Study of pancreatic and other forms of cancer.
- Dedication to teaching.
- Entrepreneurial research efforts, which have led to 12 patents.
Through the three-year-old partnership between TGen and
Scottsdale Healthcare, Dr. Von Hoff leads a nearly 40-member staff
in the research and treatment of cancer. TCRS at Scottsdale
Healthcare is conducting 35 ongoing studies, involving the
treatment of many patients with advanced cancer. The alliance works
to identify new anti-cancer agents, and strives to bring diagnostic
and treatment options to patients as fast as possible.
Dr. Von Hoff earned his medical degree from Columbia College of
Physicians and Surgeons. He held an internship and residency at the
University of California, San Francisco; conducted four years of
cancer research at the National Cancer Institute; and worked as a
faculty member at the University of Texas.
In Arizona, he has worked as Director of the Arizona Cancer Center
in Tucson and as a Clinical Professor at the University of Arizona
College of Medicine.
Dr. Von Hoff holds a presidential appointment to the National
Cancer Advisory Board, is widely published and has been a keynote
speaker at numerous national and international medical and
scientific conferences.
# # #
About TGen
The Translational Genomics Research Institute (TGen) is a
non-profit organization dedicated to conducting groundbreaking
research with life changing results. Research at TGen is focused on
helping patients with diseases such as cancer, neurological
disorders and diabetes. TGen is on the cutting edge of
translational research where investigators are able to unravel the
genetic components of common and complex diseases. Working with
collaborators in the scientific and medical communities, TGen
believes it can make a substantial contribution to the efficiency
and effectiveness of the translational process. For more
information, visit: www.tgen.org.
Press Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
[email protected]
